Synartro AB
556866-4220ActiveDeveloping sustained local injection treatments for osteoarthritis pain relief.
Overview
- 1–4
- Employees
- ≤1K SEK
- Revenue
- 2011
- Founded
Key Decision Makers
Magnus Hurst
CFO & acting CEO
Antonio Bermejo Gómez
Chief Development Officer
Mats Persson
Board Member
Maria Nyhage
Board Member
+2 more contacts in Funnelfeedr
Description
Synartro AB is a clinical stage Swedish life science company focused on developing novel local injection treatments for osteoarthritis (OA). Their core innovation lies in a patented technology that chemically binds existing, proven drugs to a base compound. This process enables sustained drug releas...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556866422001
Decision Makers
6 contacts in FunnelfeedrMagnus Hurst
CFO & acting CEO
Antonio Bermejo Gómez
Chief Development Officer
Mats Persson
Board Member
Maria Nyhage
Board Member
Fredrik Lehmann
Founder & Chairman
Other Contacts
Dr. Ali Mobasheri
Scientific Advisor
Similar Companies
20 similar companies in FunnelfeedrStayble Therapeutics AB
5–9 employeesDeveloping an injection treatment for pain caused by disc herniation.
Pharmnovo Aktiebolag
1–4 employeesDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Xintela AB
10–19 employeesDeveloping stem cell and targeted cancer therapies for unmet needs.
REGENARTI AS
Norwegian company developing peptide-enhanced gel for joint repair.
SynAct Pharma AB
5–9 employeesClinical-stage biotech resolving inflammation via novel oral therapies.
Browse More
Synartro AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo